News
A world-first human trial of a drug designed to treat the underlying cause of type 1 diabetes has begun in Australia.
Hosted on MSN27d
Bioengineering strategy uses immune-protected beta cell transplant to advance type 1 diabetes careFor T1D patients, the trouble begins with an immune system self-attack on pancreatic beta cells, the cells that produce the hormone insulin to regulate blood sugar levels. Without a reliable way ...
The new cells ... immune system. That, in turn, could pave the way to a cure for diseases like type 1 diabetes. In type 1 diabetes, immune cells, known as killer T cells, destroy pancreatic beta ...
Researchers have discovered a previously unknown type of connective tissue cells that surround cancer cells in pancreatic tumors. The newly discovered cells counteract tumor development and may ...
The immune system destroys insulin-producing cells in the pancreas. Multiple Sclerosis (MS): The immune system attacks the protective covering of nerves, affecting mobility and cognition.
4d
News Medical on MSNNew connective tissue cells could open path to pancreatic cancer treatmentResearchers at , Sweden, have discovered a previously unknown type of connective tissue cells that surround cancer cells in pancreatic tumors.
Researchers at Umeå University, Sweden, have discovered a previously unknown type of connective tissue cells that surround ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results